2Department of Cardiology Faculty of Medicine, Mersin University, Mersin
3Department of Cardiology, Faculty of Medicine, Mersin University, Mersin, Turkey
4Department of Cardiology, Faculty of Medicine, İnönü University, Malatya-Turkey
5Mersin Üniversitesi Tıp Fakültesi Kardiyoloji Anabilim Dalı, Mersin
6From Department of Cardiology Medical Faculty, Mersin University, Mersin, Turkey
Abstract
Objective: We aimed to investigate peripheral vascular complications and their relation with treatment and clinical parameters in percutaneous transluminal coronary angioplasty (PTCA) patients. Materials and Methods: We included 321 patients (aged 57±11 years) underwent PTCA between November 2001-August 2002. The age, gender, glycoprotein 2b/3a use, thrombolytic use, intraaortic balloon treatment, transient pacemaker treatment, reintervention history, hypertension, diabetes mellitus, smoking status, family history and the correlations of these parameters with local vascular complications were assessed in all patients. Results: Pseudoaneurysm incidence was significantly correlated with; age [(n=13 68.0%) p=0.0001, OR 8.38], female gender [(n=12 63.1%) p<0.015, OR 0.32], reintervention [(n=10 52.1%) p<0.004, OR 3.6], venous sheath usage [(n=12 63%) p<0.0001, OR 9.07], thrombolytic treatment [(n=5 26.3%) p<0.0001, OR 7.9], and intraaortic balloon adjustment [(n=6 31.5%) p<0.0001, OR 7.2]. No correlation was found between pseudoaneurysm incidence and glycoprotein 2b/3a treatment, smoking, diabetes mellitus, hypertension and family history. Conclusion: The present study showed that patients of female gender, with reintervention, thrombolytic treatment, venous sheath use and intraaortic balloon adjustment are at high risk for serious femoral vascular complications, especially when they are aged. Additionally, glycoprotein 2b/3a agents can be used without increased risk of peripheral vascular complications.
2Department of Cardiology Faculty of Medicine, Mersin University, Mersin
3Department of Cardiology, Faculty of Medicine, Mersin University, Mersin, Turkey
4Department of Cardiology, Faculty of Medicine, İnönü University, Malatya-Turkey
5Mersin Üniversitesi Tıp Fakültesi Kardiyoloji Anabilim Dalı, Mersin
6From Department of Cardiology Medical Faculty, Mersin University, Mersin, Turkey